FORTEC Elektronik AG (0HQQ)
London Exchange · UK · prices in EUR · close of 12 Oct 2026
Key indicators
| Last close | EUR 10.90 |
|---|---|
| 52-week range | 10.25 – 15.15 |
| Return, 1 month / 3 months | – / −20.7% |
| Return, 1 year / 3 years | −21.0% / −59.9% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 44.8% |
| Worst drawdown (1 year) | -33.4% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
FORTEC Elektronik AG is a German company that supplies electronic components and systems to industrial customers. Its business covers display solutions, embedded computing products and power supplies, which it distributes and adapts for equipment makers. Customers come from industrial automation, medical technology, transport and similar technical fields, mainly in Germany and elsewhere in Europe. The company is based in Germering, near Munich, and works closely with manufacturers whose products it represents and integrates.
FORTEC Elektronik AG trades under the code 0HQQ on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
FORTEC Elektronik AG (0HQQ) trades on the London Exchange in UK. It last closed at EUR 10.90 on 12 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 3,095 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 21.0% and over the last three months it fell 20.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 41 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.3% | ||
| From 52-week high | -28.1% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.7% | ||
| 6-month return | -0.9% | ||
| 12-month return, skipping the last month | -18.5% | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.4% | ||
| Liquidity | 2 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 48.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.4% |
|---|---|
| 1 month | – |
| 3 months | −20.7% |
| 6 months | −0.9% |
| 1 year | −21.0% |
| 3 years | −59.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 12.45 / 12.02 |
|---|---|
| Golden / death cross (60 days) | Golden, 21 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.21 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Feb 2021 | EUR 0.6000 |
| 7 Feb 2020 | EUR 0.6000 |
| 15 Feb 2019 | EUR 0.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.